Klaus-Michael Debatin

Research.com Recognitions

• 2023 - Research.com Biology and Biochemistry in Germany Leader Award

Overview

Best Publications

• Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018

  Lorenzo Galluzzi;Ilio Vitale;Stuart A. Aaronson;John M. Abrams

  6452
  Citations

• Two CD95 (APO-1/Fas) signaling pathways

  Carsten Scaffidi;Simone Fulda;Anu Srinivasan;Claudia Friesen

  4059
  Citations

• Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy.

  S. Fulda;Klaus-Michael Debatin

  3150
  Citations

• Monoclonal antibody-mediated tumor regression by induction of apoptosis

  Bernhard C. Trauth;Christiane Klas;Anke M.J. Peters;Siegfried Matzku

  2776
  Citations

• Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)

  Jens Dhein;Henning Walczak;Caroline Bäumler;Klaus-Michael Debatin

  2068
  Citations

• Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity

  F. Rieux-Laucat;F. Le Deist;C. Hivroz;I. A. G. Roberts

  1937
  Citations

• Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells.

  Claudia Friesen;Ingrid Herr;Ingrid Herr;Peter H. Krammer;Klaus Michael Debatin;Klaus Michael Debatin

  1499
  Citations

• Essential versus accessory aspects of cell death: recommendations of the NCCD 2015

  L. Galluzzi;J. M. Bravo-San Pedro;I. Vitale;S. A. Aaronson

  1178
  Citations

• Cellular stress response and apoptosis in cancer therapy

  Ingrid Herr;Klaus-Michael Debatin

  1141
  Citations

• Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo.

  Simone Fulda;Wolfgang Wick;Michael Weller;Klaus Michael Debatin;Klaus Michael Debatin

  986
  Citations

• Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells.

  F. Leithauser;J. Dhein;G. Mechtersheimer;K. Koretz

  959
  Citations

• Death receptors in chemotherapy and cancer.

  Klaus Michael Debatin;Peter H. Krammer

  704
  Citations

• The CD95 (APO-1/Fas) System Mediates Drug-induced Apoptosis in Neuroblastoma Cells

  Simone Fulda;Hauke Sieverts;Claudia Friesen;Ingrid Herr

  674
  Citations

• Activation interferes with the APO-1 pathway in mature human T cells

  Christiane Klas;Klaus michael Debatin;Richard R. Jonker;Richard R. Jonker;Peter H. Krammer

  673
  Citations

• Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation

  Wabitsch M;Brenner Re;Melzner I;Braun M

  621
  Citations

• Apoptosis pathways in cancer and cancer therapy.

  Klaus-Michael Debatin

  610
  Citations

• CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons.

  Ana Martin-Villalba;Ingrid Herr;Irmela Jeremias;Michael Hahne

  608
  Citations

• Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer.

  Simone Fulda;Martin U Küfer;Eric Meyer;Frans van Valen

  582
  Citations

• Chemotherapy: targeting the mitochondrial cell death pathway.

  Klaus-Michael Debatin;Delphine Poncet;Guido Kroemer

  554
  Citations

• Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression.

  Simone Fulda;Eric Meyer;Klaus-Michael Debatin

  542
  Citations